| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.89M | $43.99M | - | |
| Dir | 4.47M | $40.27M | - | |
| CEO | 875.0K | $7.88M | - | |
| CFO | 240.0K | $2.16M | - | |
| Other | 240.0K | $2.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Dorsey Brian57 | Chief Operating Officer | Sale+OE | 21,828 | $8.71 | $190,049.85 | -66.9% | +13.0% | - | |
| Nov 12, 2025 | Chakma Justin81 | Chief Business Officer | Sale+OE | 166,380 | $8.87 | $1,476,147.49 | -55.0% | +10.9% | - | |
| Aug 21, 2025 | Lowenthal Richard E54 | President And CEO | Sell | 50,000 | $14.49 | $724,345.00 | -4.0% | -52.3% | - | |
| Aug 21, 2025 | Scott Kathleen D.61 | Chief Financial Officer | Sale+OE | 12,500 | $15.00 | $187,500.00 | -55.5% | -52.3% | - | |
| Aug 20, 2025 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 50,000 | $14.08 | $703,755.30 | -1.9% | -51.5% | - | |
| Jul 1, 2025 | Karas Eric75 | Chief Commercial Officer | Sale+OE | 15,000 | $16.99 | $254,860.50 | -59.3% | -39.6% | - | |
| Jun 27, 2025 | Flynn James E62 | 10% Owner | Sell | 740,149 | $18.46 | $13,663,150.54 | -7.0% | -47.6% | - | |
| Jun 18, 2025 | Karas Eric75 | Chief Commercial Officer | Sale+OE | 15,000 | $16.00 | $240,000.00 | -66.1% | -40.9% | - | |
| May 20, 2025 | Fitzpatrick Alexander A83 | Chief Legal Officer | Sale+OE | 102,969 | $14.10 | $1,451,512.81 | -53.5% | -2.1% | - | |
| May 20, 2025 | Scott Kathleen D.61 | Chief Financial Officer | Sale+OE | 50,000 | $14.10 | $705,165.00 | -87.1% | -2.1% | - |